Diabetes Mellitus, Type 2

• Novo Nordisk Investigational Site — Calgary, Alberta, Canada
• Novo Nordisk Investigational Site — Edmonton, Alberta, Canada
• Novo Nordisk Investigational Site — Vancouver, British Columbia, Canada
• Novo Nordisk Investigational Site — Halifax, Nova Scotia, Canada

• University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma, United States
• University of Strathclyde — Glasgow, Scotland, United Kingdom

• Birmingham, Alabama, United States
• Montgomery, Alabama, United States
• Tempe, Arizona, United States
• Tucson, Arizona, United States

• Hospital Regional Universitario — Málaga, Malaga, Spain

Not specified

• Consultorio Privado — Guadalajara, Mexico
• Investigación Clínica Especializada — Guadalajara, Mexico
• Consultorio Privado en Unidad de Patología Clínica — Guadalajara, Mexico
• Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán — Mexico City, Mexico

• Federally Qualified Health Centers & Vanderbilt Primary Care Clinics — Nashville, Tennessee, United States

• Novo Nordisk Investigational Site — Muscle Shoals, Alabama, United States
• Novo Nordisk Investigational Site — Tuscumbia, Alabama, United States
• Novo Nordisk Investigational Site — Glendale, Arizona, United States
• Novo Nordisk Investigational Site — Glendale, Arizona, United States

• Celerion — Tempe, Arizona, United States
• Clinical Pharmacology of Miami, Inc. — Miami, Florida, United States
• Orlando Clinical Research Center — Orlando, Florida, United States
• Celerion — Lincoln, Nebraska, United States

Not specified